Cefmenoxime
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | Intramuscular, intravenous | 
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | 100% (given IM) | 
| Protein binding | 50% to 70% | 
| Metabolism | Negligible | 
| Elimination half-life | 1 hour | 
| Excretion | Kidney, unchanged | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C16H17N9O5S3 | 
| Molar mass | 511.55 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Cefmenoxime is a third-generation cephalosporin antibiotic.